AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024
20 March 2024 - 7:01AM
Business Wire
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative
medical technology company focused on restoring healthy blood flow
in the body’s vascular system, expanding cancer treatment options
and improving patient quality of life, today announced that it will
report financial results for the third quarter of fiscal year 2024
before the market open on Thursday, April 4, 2024. The Company’s
management will host a conference call at 8:00 a.m. ET the same day
to discuss the results.
To participate in the conference call, dial 1-877-407-0784
(domestic) or +1-201-689-8560 (international) and refer to the
passcode 13745239.
This conference call will also be webcast and can be accessed
from the “Investors” section of the AngioDynamics website at
www.angiodynamics.com. The webcast replay of the call will be
available at the same site approximately one hour after the end of
the call.
A recording of the call will also be available from 10:00 a.m.
ET on Thursday, April 4, 2024, until 11:59 p.m. ET on Thursday,
April 11, 2024. To hear this recording, dial 1-844-512-2921
(domestic) or +1-412-317-6671 (international) and enter the
passcode 13745239.
About AngioDynamics, Inc.
AngioDynamics is a leading and transformative medical technology
company focused on restoring healthy blood flow in the body’s
vascular system, expanding cancer treatment options and improving
patient quality of life.
The Company’s innovative technologies and devices are chosen by
talented physicians in fast-growing healthcare markets to treat
unmet patient needs. For more information, visit
www.angiodynamics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240319173188/en/
Investor Contact: AngioDynamics, Inc. Stephen Trowbridge,
Executive Vice President & CFO (518) 795-1408
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Mar 2024 to Apr 2024
AngioDynamics (NASDAQ:ANGO)
Historical Stock Chart
From Apr 2023 to Apr 2024